DUBLIN, Nov. 7, 2023
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that
management will participate in a fireside chat at the Jefferies
London Healthcare Conference on Tuesday,
Nov. 14, 2023 at 12:00 p.m. ET
(5:00 p.m. GMT). The live webcast may
be accessed under the Investors tab on www.alkermes.com and will be
archived for 14 days.
About Alkermes plc
Alkermes plc is a
fully-integrated, global biopharmaceutical company developing
innovative medicines in the fields of neuroscience and oncology.
The company has a portfolio of proprietary commercial products
focused on alcohol dependence, opioid dependence, schizophrenia and
bipolar I disorder, and a pipeline of product candidates in
development for neurological disorders and cancer. Headquartered
in Dublin, Ireland, Alkermes has a research and
development center in Waltham, Massachusetts; a research
and manufacturing facility in Athlone, Ireland; and a
manufacturing facility in Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-jefferies-london-healthcare-conference-301980646.html
SOURCE Alkermes plc